Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists - 1 Mar 2016

Carmina Enrico, Campagna Anna M, Fruzzetti Franca, Lobo Rogerio A

Abstract excerpt

OBJECTIVE: This study was designed to assess the value of serum anti-Müllerian hormone (AMH) in the diagnosis of polycystic ovary syndrome (PCOS) in various phenotypes and to assess ovarian ultrasound parameters. METHODS: We performed a retrospective matched controlled study of 113 females with various PCOS phenotypes and 47 matched controls. The diagnostic utility of AMH measurement and ovarian ultrasound were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Mullerian Hormone
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Polycystic Ovary Syndrome

Share to ROC Curve

Share to Ultrasonography

Share to Young Adult

Source

Identifiers

PMID: 26523627
DOI: 10.4158/EP15903.OR

Genes

AMH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.PMID 26523627Read ↗

The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.Semantic proximity Read ↗

The Diagnostic Performance of Antimullerian Hormone for Polycystic Ovarian Syndrome and Polycystic Ovarian MorphologySemantic proximity Read ↗

Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndromeSemantic proximity Read ↗

The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.Semantic proximity Read ↗

Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.Semantic proximity Read ↗

Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.Semantic proximity Read ↗

Association between anti‐Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in JapanSemantic proximity Read ↗

The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndromeSemantic proximity Read ↗

Serum Anti-Mullerian Hormone (AMH) Levels Among Different PCOS Phenotypes and Its Correlation with Clinical, Endocrine, and Metabolic Markers of PCOS.Semantic proximity Read ↗

AMH levels and diagnosis in PCOS phenotype D.Semantic proximity Read ↗

Age-stratified thresholds of anti-Müllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold.Semantic proximity Read ↗

Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.